Barclays
ADAG

Barclays’s Adagene ADAG Stock Holding History

Barclays’s Portfolio ADAG Stock Details ADAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-400
Closed -$1.57K – 5337
2026
Q1 		$1.57K Buy
+400
New +$1.16K ﹤0.01% 4872
2025
Q2 		– Sell
-122,516
Closed -$186K – 5216
2025
Q1 		$186K Sell
122,516
-64,387
-34% -$120K ﹤0.01% 4084
2024
Q4 		$372K Hold
186,903
– – ﹤0.01% 4001
2024
Q3 		$415K Hold
186,903
– – ﹤0.01% 3890
2024
Q2 		$572K Buy
186,903
+11,773
+7% +$31.6K ﹤0.01% 2967
2024
Q1 		$490K Buy
+175,130
New +$545K ﹤0.01% 3606

Other funds holding ADAG

JT
Jupiter Topco New York $245B AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
EAM
Exome Asset Management New York $162M AUM 259.04% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Barclays's ADAG Position: Q2 2026 in Review

Barclays sold out of Adagene (ADAG) in Q2 2026, closing a stake of 400 shares — an estimated $1.57K sold.

Barclays first reported a position in ADAG in Q1 2024 and held it in 6 quarters. The position peaked at $572K in Q2 2024. 35 funds tracked by Wall St. Rank hold ADAG as of Q2 2026.

  • Barclays reported no remaining Adagene position as of Q2 2026 after selling out during the quarter.
  • Barclays sold 400 Adagene shares in Q2 2026, an estimated $1.57K.
  • Barclays first reported a position in Adagene in Q1 2024 and held it in 6 quarters.
  • Barclays's Adagene position peaked at $572K in Q2 2024.
  • 35 funds tracked by Wall St. Rank held Adagene as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.